ReviewAnnual review of biomedical data science2026
Privacy and Security Throughout the Health Data Life Cycle: From Primary Care to Research Networks.
Review in Annual review of biomedical data science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Health data are increasingly generated, shared, and analyzed across an ever-growing collection of settings. While these developments enable new forms of biomedical discovery and clinical decision support, they also introduce evolving privacy, security, and trust challenges that extend beyond traditional regulatory and technical frameworks. In this review, we characterize the various risks and protections throughout the health data life cycle, from data generation and primary use in healthcare to secondary use in research and artificial intelligence (AI) model development. We discuss how regulation, organizational practices, and technological choices shape data protection requirements, and we discuss and contextualize emerging threats, such as incidental disclosures through AI tools. We further review technical approaches for mitigating these risks, including access control and auditing, re-identification risk assessment and statistical mechanisms for risk mitigation (e.g., differential privacy), and synthetic data generation. We also consider how collaboration across disparate organizations may be achieved through federated learning mechanisms and cryptographic technologies, such as secure multiparty computation. Throughout, we highlight trade-offs between privacy protection and data utility, and we articulate practical challenges in deploying these methods at scale. We conclude by identifying open issues for the field, including the need for standardized metrics and greater transparency to support trust in data-driven healthcare and research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.